Stocks News

LAST PRICE
106.1300
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
105.4200/ 4
Ask / Lots
105.4900/ 6
Open / Previous Close
--- / 106.1300
Day Range
---
52 Week Range
Low 94.7313
High 148.1500
Volume
22,466
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ Novo Nordisk A/S Stock Rises Thursday, Outperforms Market, from 19 hours ago by Dow Jones
  19 hours ago by Dow Jones
  Companies Mentioned: NVO
  
  This article was automatically generated using Dow Jones technology.
  
  Shares of Novo Nordisk A/S rose 0.6% to DKK747.60 Thursday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.5% to 2,608.69.
Nov 27, 2024
- Sector Update: Health Care Stocks Advance Wednesday Afternoon, from 1:42PM ET on Wednesday Nov 27, 2024 by MT Newswires
  1:42PM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: NVO, KKR, CRVO, GRFS, BAM
  01:42 PM EST, 11/27/2024 (MT Newswires) -- Health care stocks were higher Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.7%. The iShares Biotechnology ETF (IBB) rose 0.8%. In corp...
- DJ Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market, from 12:03PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:03PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: NVO
  
  This article was automatically generated using Dow Jones technology.
  
  Shares of Novo Nordisk A/S shed 2.0% to DKK743.40 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,595.10.
- Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight, from 8:30AM ET on Wednesday Nov 27, 2024 by MT Newswires
  8:30AM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: NVO, KKR
  08:30 AM EST, 11/27/2024 (MT Newswires) -- Novo Nordisk (NVO) and KKR's (KKR) joint acquisition of Sylvan International Biotechnology in China was cleared by the EU's antitrust review, the European Commission said Wednesday. The Commission said it f...
Nov 26, 2024
- DJ White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs -- 2nd Update, from 3:41PM ET on Tuesday Nov 26, 2024 by Dow Jones
  3:41PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: LLY, NVO
  
  By Liz Essley Whyte and Peter Loftus
  
  The Biden administration is proposing that Medicare and Medicaid pay for popular anti-obesity drugs for more Americans.
  
  The White House said Tuesday it is moving to make Medicare and Medicaid cover anti-obesity drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound for people who are obese, even if they don't have other diseases like diabetes.

Nov 27, 2024
- Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing, from 5:32PM ET on Wednesday Nov 27, 2024 by MT Newswires
  5:32PM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: ALNY
- Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing, from 5:29PM ET on Wednesday Nov 27, 2024 by MT Newswires
  5:29PM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: ALNY
- Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing, from 5:29PM ET on Wednesday Nov 27, 2024 by MT Newswires
  5:29PM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: ALNY
- Royalty Pharma to Present at Upcoming Investor Conferences, from 4:15PM ET on Wednesday Nov 27, 2024 by Dow Jones
  4:15PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: RPRX
- Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones
  7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: ALNY
Nov 26, 2024
- European Equities Close Lower in Tuesday Trading, from 12:21PM ET on Tuesday Nov 26, 2024 by MT Newswires
  12:21PM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: STLA, MT, NVO, CTLT
- Update: Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover, from 5:21AM ET on Tuesday Nov 26, 2024 by MT Newswires
  5:21AM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: NVO, CTLT
Nov 25, 2024
- Sector Update: Health Care Stocks Edge Higher Premarket Monday, from 9:09AM ET on Monday Nov 25, 2024 by MT Newswires
  9:09AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: IBB, SAVA, XLV, ALNY, BHVN
- Alnylam Says FDA Accepts Supplemental NDA for Vutrisiran to Treat ATTR Amyloidosis With Cardiomyopathy, from 8:11AM ET on Monday Nov 25, 2024 by MT Newswires
  8:11AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: ALNY
- Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover, from 7:53AM ET on Monday Nov 25, 2024 by MT Newswires
  7:53AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: NVO, CTLT

Novo Nordisk A/S
NYSE:NVOUnited States

Search Criteria

Yesterday

DJ Novo Nordisk A/S Stock Rises Thursday, Outperforms Market, from 19 hours ago by Dow Jones

Nov 27, 2024

Sector Update: Health Care Stocks Advance Wednesday Afternoon, from 1:42PM ET on Wednesday Nov 27, 2024 by MT Newswires

DJ Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market, from 12:03PM ET on Wednesday Nov 27, 2024 by Dow Jones

Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight, from 8:30AM ET on Wednesday Nov 27, 2024 by MT Newswires

Nov 26, 2024

DJ White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs -- 2nd Update, from 3:41PM ET on Tuesday Nov 26, 2024 by Dow Jones

Peers Headlines

Nov 27, 2024

Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing, from 5:32PM ET on Wednesday Nov 27, 2024 by MT Newswires

Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing, from 5:29PM ET on Wednesday Nov 27, 2024 by MT Newswires

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing, from 5:29PM ET on Wednesday Nov 27, 2024 by MT Newswires

Royalty Pharma to Present at Upcoming Investor Conferences, from 4:15PM ET on Wednesday Nov 27, 2024 by Dow Jones

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 26, 2024

European Equities Close Lower in Tuesday Trading, from 12:21PM ET on Tuesday Nov 26, 2024 by MT Newswires

Update: Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover, from 5:21AM ET on Tuesday Nov 26, 2024 by MT Newswires

Nov 25, 2024

Sector Update: Health Care Stocks Edge Higher Premarket Monday, from 9:09AM ET on Monday Nov 25, 2024 by MT Newswires

Alnylam Says FDA Accepts Supplemental NDA for Vutrisiran to Treat ATTR Amyloidosis With Cardiomyopathy, from 8:11AM ET on Monday Nov 25, 2024 by MT Newswires

Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover, from 7:53AM ET on Monday Nov 25, 2024 by MT Newswires